Geron Company Profile

07:06 EDT 20th March 2019 | BioPortfolio

Geron Corporation is a biopharmaceutical company focused on discovering and developing therapeutic and diagnostic products to treat cancer and other age-related degenerative diseases. The Company is uniquely positioned to pursue this goal given its breakthrough discoveries surrounding telomeres, telomerase and embryonic stem cells. Telomeres are structures at the ends of chromosomes that the Company has shown act as a molecular "clock" of cellular aging. Telomerase is an enzyme which appears to stop the "clock" and confers cellular immortality. By manipulating telomerelength through telomerase regulation, the Company aims to kill cancer cells where telomerase is abnormally turned on. Conversely, the Company seeks to increase the lifespan of normal cells, where telomerase is normally turned off, to treat age-related diseases such as atherosclerosis, macular degeneration and osteoporosis. Embryonic stem cells are telomerase positive and therefore have an unlimited ability to divide. They have the capability to turn into any and all

cell types and tissues in the body. The Company aims to use human embryonic stem cells as a source of replacement cells for transplantation medicine to treat patients suffering from congestive heart failure, Parkinson's Disease, diabetes, osteoarthritis, osteoporosis, cancers, skin disorders and other age-related conditions.


230 Constitution Drive
Menlo Park
United States of America


Phone: 650 473 7700
Fax: 650 473 7750

News Articles [77 Associated News Articles listed on BioPortfolio]

Aleksandra Rizo Departs Celgene for Geron Chief Medical Post

Aleksandra Rizo has been appointed chief medical officer of Geron (NASDAQ: GERN). Rizo comes to the Menlo Park, CA, drug developer from Summit, NJ-based Celgene (NASDAQ: CELG), where she was executive...

Geron’s Drug Alliance with Janssen Terminated, Shares Plummet 68%

Four years after Geron landed a pharmaceutical partner to co-develop its lead drug, the Menlo Park, CA, biotech is now moving forward with the compound on its own. Janssen Biotech is ending the collab...

J&J gives up on Geron's cancer drug

Geron, which saw shares fall 70% by market's open Thursday, said it will power on with imetelstat's development, with a Phase 3 testing planned for mid-2019.

Geron and Janssen Cancel Collaboration, Share Price Drops

Geron and Johnson and Johnson’s subsidiary, Janssen Biotech, have announced they have terminated their partnership of a drug development for two different blood disorders. The post Geron and Janssen...

Geron Cancels Janssen Collaboration, Share Price Drops

Geron and Johnson & Johnson’s subsidiary, Janssen Biotech, have terminated their partnership on development of a drug for two different blood disorders. The post Geron Cancels Janssen Collabora...

Janssen terminates cancer drug development deal with Geron

In November 2014, Janssen signed an exclusive worldwide collaboration and license agreement with Geron for the development and commercialization of imetelstat in oncology, including hematologic myeloi...

Geron Names CEO John Scarlett As Chairman, Succeeding Hoyoung Huh

WASHINGTON (dpa-AFX) - Geron Corp. (GERN) on Monday announced changes to the leadership structure of the company's Board of Directors. The company noted that for personal reasons, effective Decemb...

J&J bails on Geron cancer drug

Johnson & Johnson's Janssen Biotech will end a licensing partnership with Geron Corp., returning rights to the biotech’s sole product candidate, imetelstat.

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [9 Associated Companies listed on BioPortfolio]

Geron Corporation

Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The ...

Genetron Health (Beijjing) Co. Ltd

As a leader in cancer precision medicine in China, Genetron is practicing the research and development concept of “exploration, discovery, application and change”. Genet...

Asterias Biotherapeutics, Inc.

Asterias Biotherapeutics is a subsidiary of BioTime, Inc., whose mission is to acquire and develop best in class cell therapy product candidates. Our first acquisition was the ste...


Geron Corporation is a biopharmaceutical company focused on discovering and developing therapeutic and diagnostic products to treat cancer and other age-related degenerative diseases. The Company is u...

T.A. Sciences

T.A. Sciences is the first company in the world to offer its clients the ability to fight aging through the emerging science of telomere biology. T.A. Sciences was founded by Noel T...

More Information about "Geron" on BioPortfolio

We have published hundreds of Geron news stories on BioPortfolio along with dozens of Geron Clinical Trials and PubMed Articles about Geron for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Geron Companies in our database. You can also find out about relevant Geron Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Corporate Database Quicklinks

Searches Linking to this Company Record